28 November 2023 in Parodontologiya
Relevance. Osteoporosis and chronic periodontitis are serious issues of modern life. The hypothesis that these two diseases are associated is still open-ended and doesn’t allow setting the record straight for the lack of sufficient evidence.Purpose. The study aimed to detect the relationship between periodontal health parameters and mineral bone density characteristics in postmenopausal women.Material and methods. The study examined 109 female patients with diagnosed moderate chronic generalized periodontitis (К05.31). The participants formed two groups: the main group (76 women) and the control group (33 women). Dual-energy X-ray absorptiometry, FRAХ® and CCI assessed the mineral bone density and patients’ systemic health. Dental status was evaluated using the OHI-S, CAL, PPD, PMA, PI, and PBI. X-ray assessment was based on the Fuchs index for upper and lower jaws, and the mandibular cortical index (MCI) was evaluated by CBCT scans in Galaxis Galileos software (Sirona), Orthophos SL CBCT scanner. The data were statistically analysed using licensed STATISTICA 13.3 software. In descriptive statistics for variables, the median was quartiles corresponding to the 25th percentile and the 75th percentile. The Shapiro-Wilk test and χ2 (chi-square) evaluated the normality of variables.Results. Periodontal pocket depth (PPD) was 4.44 (4.30:4.20:4.50) in the main group. The cumulative change in the clinical attachment level (CAL) was 5.53 (5.50:5.40:5.80), which was significantly higher than the control group parameters (р < 0.001). Bone mineral density of L1-L4 vertebrae corresponded to osteopenia (g/cm2) -0.83 (-080: -0.78: -0.91), spine (Neck) Т-score was -1.70 (-1.7: -2.2: -2.0). In the patients of the control group, the CBCT did not show any signs of inf lammatory destruction, and the DXA test did not reveal any loss of bone mineral densit y.Conclusion. There are mean significant (less than 0.05) correlations between right femoral neck Т-scores and periodontal pocket depth parameters (R = -0.39) and between the same parameter and the clinical attachment level (CAL) (R = -0.37). A significantly high degree of negative correlation is between the spine Т-score of L1-L4 and PPD, correlation coefficient (R = -0.72).
28 November 2023 in Parodontologiya
Relevance. Osteoporosis and chronic periodontitis are serious issues of modern life. The hypothesis that these two diseases are associated is still open-ended and doesn’t allow setting the record straight for the lack of sufficient evidence.Purpose. The study aimed to detect the relationship between periodontal health parameters and mineral bone density characteristics in postmenopausal women.Material and methods. The study examined 109 female patients with diagnosed moderate chronic generalized periodontitis (К05.31). The participants formed two groups: the main group (76 women) and the control group (33 women). Dual-energy X-ray absorptiometry, FRAХ® and CCI assessed the mineral bone density and patients’ systemic health. Dental status was evaluated using the OHI-S, CAL, PPD, PMA, PI, and PBI. X-ray assessment was based on the Fuchs index for upper and lower jaws, and the mandibular cortical index (MCI) was evaluated by CBCT scans in Galaxis Galileos software (Sirona), Orthophos SL CBCT scanner. The data were statistically analysed using licensed STATISTICA 13.3 software. In descriptive statistics for variables, the median was quartiles corresponding to the 25th percentile and the 75th percentile. The Shapiro-Wilk test and χ2 (chi-square) evaluated the normality of variables.Results. Periodontal pocket depth (PPD) was 4.44 (4.30:4.20:4.50) in the main group. The cumulative change in the clinical attachment level (CAL) was 5.53 (5.50:5.40:5.80), which was significantly higher than the control group parameters (р < 0.001). Bone mineral density of L1-L4 vertebrae corresponded to osteopenia (g/cm2) -0.83 (-080: -0.78: -0.91), spine (Neck) Т-score was -1.70 (-1.7: -2.2: -2.0). In the patients of the control group, the CBCT did not show any signs of inf lammatory destruction, and the DXA test did not reveal any loss of bone mineral densit y.Conclusion. There are mean significant (less than 0.05) correlations between right femoral neck Т-scores and periodontal pocket depth parameters (R = -0.39) and between the same parameter and the clinical attachment level (CAL) (R = -0.37). A significantly high degree of negative correlation is between the spine Т-score of L1-L4 and PPD, correlation coefficient (R = -0.72).
25 October 2025 in Children's medicine of the North-West
Введение. Синдром Криглера–Найяра характеризуется генетически детерминированным нарушением трансформации фракций билирубина в гепатоцитах вследствие недостаточного (II тип) либо полного (I тип) отсутствия фермента уридиндифосфатглюкуронидазы-1. Синдром имеет вариабельную экспрессивность, а степень снижения активности фермента и клинические проявления варьируют у пациентов, при нарастании неконъюгированной гипербилирубинемии в крови отмечается желтуха с формированием билирубиновой энцефалопатии. Диагноз подтверждается при обнаружении мутаций на обеих копиях гена UGT1A1. Привлекательным терапевтическим подходом становится генная терапия синдрома Криглера–Найяра II типа, которая позволит заменить трансплантацию печени на альтернативную технологию лечения. Данная тактика поможет больным улучшить позитивный прогноз на качество и продолжительность их жизни. Цель исследования — представить наблюдение редкого в практике врача-педиатра синдрома Криглера–Найяра II типа, особенности диагностики и перспективы внедрения новой технологии лечения. Основные положения. В статье описан клинический случай дебюта синдрома Криглера–Найяра II типа в периоде новорожденности у девочки из двойни. Представлены этапы диагностического поиска, проведен анализ результатов молекулярно-генетического обследования. Изложены сложности ведения ребенка на участке из-за недостаточной эффективности существующего симптоматического протокола лечения, перспективы применения современных генно-инженерных лечебных технологий. Заключение. Диагноз «синдром Криглера–Найяра II типа» установлен после проведения молекулярно-генетического исследования. Тактика курации пациента участковым педиатром и врачами узких специальностей требует разработки единых протоколов наблюдения и патогенетического лечения, улучшающих качество жизни. Introduction. Crigler–Najjar syndrome is characterized by a genetically determined disorder of transformation of bilirubin fractions in hepatocytes due to insufficient (type II) or complete (type I) absence of the enzyme uridine diphosphate glucuronidase-1. The syndrome has variable expressivity, and the degree of decrease in enzyme activity and clinical manifestations vary among patients; with an increase in unconjugated hyperbilirubinemia in the blood, jaundice is observed with the formation of bilirubin encephalopathy. The diagnosis is confirmed by detecting mutations in both copies of the UGT1A1 gene. Gene therapy for Crigler–Najjar syndrome type II is emerging as an attractive therapeutic approach, allowing patients to replace liver transplantation with an alternative treatment option. This tactic will help patients improve their prognosis for the quality and length of their lives. The aim of the study is to present a case report of type II Crigler–Najjar syndrome, rarely encountered in pediatric practice, diagnostic features and potential for implementing new therapeutic technologies. Basic provisions. The article describes a clinical case of type II Crigler–Najjar syndrome manifesting in the neonatal period in one of a pair of twins. The stages of the diagnostic work-up are outlined, and the results of molecular genetic testing are analyzed. The challenges of managing the child in outpatient settings due to the limited effectiveness of the current symptomatic treatment protocol are discussed, along with the prospects for applying modern genetically engineered therapeutic technologies. Conclusion. The diagnosis of Crigler–Najjar syndrome type II was established after conducting a molecular genetic study. The tactics of patient supervision by a district pediatrician and doctors of narrow specialties require the development of unified protocols for monitoring and pathogenetic treatment that improve the quality of life of children.